| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109
To characterize the role of GM-CSF in pulmonary fibrosis, we have studied bleomycin-induced fibrosis in wild-type mice vs mice with a targeted deletion of the GM-CSF gene (GM-CSF-/- mice). Without GM-CSF, pulmonary fibrosis was worse both histologically and quantitatively. These changes were not related to enhanced recruitment of inflammatory cells because wild-type and GM-CSF-/- mice recruited equivalent numbers of cells to the lung following bleomycin. Interestingly, recruitment of eosinophils was absent in GM-CSF-/- mice. We investigated whether the enhanced fibrotic response in GM-CSF-/- animals was due to a deficiency in an endogenous down-regulator of fibrogenesis. Analysis of whole lung homogenates from saline- or bleomycin-treated mice revealed that GM-CSF-/- animals had reduced levels of PGE2. Additionally, alveolar macrophages were harvested from wild-type and GM-CSF-/- mice that had been exposed to bleomycin. Although bleomycin treatment impaired the ability of alveolar macrophages from wild-type mice to synthesize PGE2, alveolar macrophages from GM-CSF-/- mice exhibited a significantly greater defect in PGE2 synthesis than did wild-type cells. Exogenous addition of GM-CSF to alveolar macrophages reversed the PGE2 synthesis defect in vitro. Administration of the PG synthesis inhibitor, indomethacin, to wild-type mice during the fibrogenic phase postbleomycin worsened the severity of fibrosis, implying a causal role for PGE2 deficiency in the evolution of the fibrotic lesion. These data demonstrate that GM-CSF deficiency results in enhanced fibrogenesis in bleomycin-induced pulmonary fibrosis and indicate that one mechanism for this effect is impaired production of the potent antifibrotic eicosanoid, PGE2.
This article has been cited by other articles:
|
|
 |
|
  N. Uozumi, Y. Kita, and T. Shimizu Modulation of Lipid and Protein Mediators of Inflammation by Cytosolic Phospholipase A2{alpha} during Experimental Sepsis J. Immunol., September 1, 2008; 181(5): 3558 - 3566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Ballinger, L. L. N. Hubbard, T. R. McMillan, G. B. Toews, M. Peters-Golden, R. Paine III, and B. B. Moore Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L114 - L122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Huang and M. Peters-Golden Eicosanoid Lipid Mediators in Fibrotic Lung Diseases: Ready for Prime Time? Chest, June 1, 2008; 133(6): 1442 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. White, Q. Ding, B. B. Moore, M. Peters-Golden, L. B. Ware, M. A. Matthay, and M. A. Olman Prostaglandin E2 Mediates IL-1 -Related Fibroblast Mitogenic Effects in Acute Lung Injury through Differential Utilization of Prostanoid Receptors J. Immunol., January 1, 2008; 180(1): 637 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Sandulache, J. B. Chafin, H.-S. Li-Korotky, T. D. Otteson, J. E. Dohar, and P. A. Hebda Elucidating the Role of Interleukin 1beta and Prostaglandin E2 in Upper Airway Mucosal Wound Healing Arch Otolaryngol Head Neck Surg, April 1, 2007; 133(4): 365 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Ballinger, D. M. Aronoff, T. R. McMillan, K. R. Cooke, K. Olkiewicz, G. B. Toews, M. Peters-Golden, and B. B. Moore Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation J. Immunol., October 15, 2006; 177(8): 5499 - 5508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Horikawa, M. Fujimoto, M. Hasegawa, T. Matsushita, Y. Hamaguchi, A. Kawasuji, Y. Matsushita, T. Fujita, F. Ogawa, K. Takehara, et al. E- and P-Selectins Synergistically Inhibit Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., September 1, 2006; 169(3): 740 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Soberman and P. Christmas Revisiting prostacyclin: new directions in pulmonary fibrosis and inflammation Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L142 - L143. [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Ballinger, R. Paine III, C. H. C. Serezani, D. M. Aronoff, E. S. Choi, T. J. Standiford, G. B. Toews, and B. B. Moore Role of Granulocyte Macrophage Colony-Stimulating Factor during Gram-Negative Lung Infection with Pseudomonas aeruginosa Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 766 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Y. Park and J. W. Christman Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Y. Lee, C. Schroedl, J. K. Brunelle, L. J. Buccellato, O. I. Akinci, H. Kaneto, C. Snyder, J. Eisenbart, G. R. S. Budinger, and N. S. Chandel Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L521 - L528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakatani-Okuda, H. Ueda, S.-i. Kashiwamura, A. Sekiyama, A. Kubota, Y. Fujita, S. Adachi, Y. Tsuji, T. Tanizawa, and H. Okamura Protection against bleomycin-induced lung injury by IL-18 in mice Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L280 - L287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Moore, M. N. Ballinger, E. S. White, M. E. Green, A. B. Herrygers, C. A. Wilke, G. B. Toews, and M. Peters-Golden Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2 J. Immunol., May 1, 2005; 174(9): 5644 - 5649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Barbarin, Z. Xing, M. Delos, D. Lison, and F. Huaux Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L841 - L848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murakawa, M. M. Kerklo, M. R. Zamora, Y. Wei, R. G. Gill, P. M. Henson, F. L. Grover, and M. R. Nicolls Simultaneous LFA-1 and CD40 Ligand Antagonism Prevents Airway Remodeling in Orthotopic Airway Transplantation: Implications for the Role of Respiratory Epithelium as a Modulator of Fibrosis J. Immunol., April 1, 2005; 174(7): 3869 - 3879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-H. Chen, R. A. McDonald, J. C. Wells, G. B. Huffnagle, N. W. Lukacs, and G. B. Toews The Gamma Interferon Receptor Is Required for the Protective Pulmonary Inflammatory Response to Cryptococcus neoformans Infect. Immun., March 1, 2005; 73(3): 1788 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arras, J. Louahed, J.-F. Heilier, M. Delos, F. Brombacher, J.-C. Renauld, D. Lison, and F. Huaux IL-9 Protects against Bleomycin-Induced Lung Injury: Involvement of Prostaglandins Am. J. Pathol., January 1, 2005; 166(1): 107 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hodges, R. G. Jenkins, C. P.D. Wheeler-Jones, D. M. Copeman, S. E. Bottoms, G. J. Bellingan, C. B. Nanthakumar, G. J. Laurent, S. L. Hart, M. L. Foster, et al. Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production Am. J. Pathol., November 1, 2004; 165(5): 1663 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Barbarin, M. Arras, P. Misson, M. Delos, B. McGarry, S. H. Phan, D. Lison, and F. Huaux Characterization of the Effect of Interleukin-10 on Silica-Induced Lung Fibrosis in Mice Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 78 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Kolodsick, G. B. Toews, C. Jakubzick, C. Hogaboam, T. A. Moore, A. McKenzie, C. A. Wilke, C. J. Chrisman, and B. B. Moore Protection from Fluorescein Isothiocyanate-Induced Fibrosis in IL-13-Deficient, but Not IL-4-Deficient, Mice Results from Impaired Collagen Synthesis by Fibroblasts J. Immunol., April 1, 2004; 172(7): 4068 - 4076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Beller, D. S. Friend, A. Maekawa, B. K. Lam, K. F. Austen, and Y. Kanaoka Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis PNAS, March 2, 2004; 101(9): 3047 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Christensen, M. Du, B. Moore, S. Morris, G. B. Toews, and R. Paine III Expression and functional implications of CCR2 expression on murine alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L68 - L72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Kolodsick, M. Peters-Golden, J. Larios, G. B. Toews, V. J. Thannickal, and B. B. Moore Prostaglandin E2 Inhibits Fibroblast to Myofibroblast Transition via E. Prostanoid Receptor 2 Signaling and Cyclic Adenosine Monophosphate Elevation Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 537 - 544. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Charbeneau, P. J. Christensen, C. J. Chrisman, R. Paine III, G. B. Toews, M. Peters-Golden, and B. B. Moore Impaired synthesis of prostaglandin E2 by lung fibroblasts and alveolar epithelial cells from GM-CSF-/- mice: implications for fibroproliferation Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1103 - L1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Moore, M. Peters-Golden, P. J. Christensen, V. Lama, W. A. Kuziel, R. Paine III, and G. B. Toews Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2 Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L342 - L349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lama, B. B. Moore, P. Christensen, G. B. Toews, and M. Peters-Golden Prostaglandin E2 Synthesis and Suppression of Fibroblast Proliferation by Alveolar Epithelial Cells Is Cyclooxygenase-2-Dependent Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 752 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hamaguchi, Y. Nishizawa, M. Yasui, M. Hasegawa, Y. Kaburagi, K. Komura, T. Nagaoka, E. Saito, Y. Shimada, K. Takehara, et al. Intercellular Adhesion Molecule-1 and L-Selectin Regulate Bleomycin-Induced Lung Fibrosis Am. J. Pathol., November 1, 2002; 161(5): 1607 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Burg, V. Krump-Konvalinkova, F. Bittinger, and C. J. Kirkpatrick GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L460 - L467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. PETERS-GOLDEN, M. BAILIE, T. MARSHALL, C. WILKE, S. H. PHAN, G. B. TOEWS, and B. B. MOORE Protection from Pulmonary Fibrosis in Leukotriene-Deficient Mice Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 229 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Moore, R. Paine III, P. J. Christensen, T. A. Moore, S. Sitterding, R. Ngan, C. A. Wilke, W. A. Kuziel, and G. B. Toews Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling J. Immunol., October 15, 2001; 167(8): 4368 - 4377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.B. Toews Cytokines and the lung Eur. Respir. J., July 2, 2001; 18(34_suppl): 3S - 17s. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
